The DOI matches its Crossref record.
Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease
Abstract
Alzheimers disease (AD) is the most common neurodegenerative disorder that affects the elderly. The increase of lifeexpectancy is transforming AD into a major health-care problem. AD is characterized by a progressive impairment of memory and other cognitive skills leading to dementia. The major pathogenic factor associated to AD seems to be amyloid-beta peptide (Aβ) oligomers that tend to accumulate extracellularly as amyloid deposits and are associated with reactive microglia and astrocytes as well as with degeneration of neuronal processes. The involvement of microglia and astrocytes in the onset and progress of neurodegenerative process in AD is becoming increasingly recognized, albeit it is commonly accepted that neuroinflammation and oxidative stress can have both detrimental and beneficial influences on the neural tissue. However, little is known about the interplay of microglia, astrocytes and neurons in response to Aβ, especially in the early phases of AD. This review discusses current knowledge about the involvement of neuroinflammation in AD pathogenesis, focusing on phenotypic and functional responses of microglia, astrocytes and neurons in this process. The abnormal production by glia cells of pro-inflammatory cytokines, chemokines and the complement system, as well as reactive oxygen and nitrogen species, can disrupt nerve terminals activity causing dysfunction and loss of synapses, which correlates with memory decline; these are phenomena preceding the neuronal death associated with late stages of AD. Thus, therapeutic strategies directed at controlling the activation of microglia and astrocytes and the excessive production of pro-inflammatory and pro-oxidant factors may be valuable to control neurodegeneration in dementia. Keywords: Amyloid-beta, microglia, astrocytes, neurons, pro-inflammatory factors, reactive oxygen species, neurodegeneration, Alzheimer's disease, Dementia, Neuroinflammation, Pro-oxidant factors, Memory, Mild cognitive impairment, CNS, cytokines, prostaglandins, IL-1, PPAR-g, Complement system, Amyloid pla, Trophic factors, Glia-derived neurotrophic factor, Glial scars, Ca2+ overload, Homeostasis, Antioxidants, Electron transport chain, Curcumin, Quercetin
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, they have an impact on the unsaturated fatty acids chain of membrane phospholipids, causing cell lysis [116,117,118].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“This immune response causes both an invasion of the glia by circulating immune cells and the production of pro-inflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL) IL-1β and IL-6-, nitric oxide (NO), prostaglandin E2 (PGE2), chemokines, and ROS.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“AD is also induced by neuroinflammation processes that occur as a brain immune barrier [117,154].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“Oxidative stress associated with Aβ pathology plays an important role in the death of neurons in the AD brain [82,83,84,85].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [82]
Citations
Cited by
Sorted by citations
Items 501–600 of 678
Eckhardt, F. S., Pauliny, A., Rollings, N., Mutschmann, F., Olsson, M. M., Kraus, C., & Kappeler, P. M. (2020) · BMC Evolutionary Biology · doi:10.1186/s12862-020-01724-2 · Cited by 8
da Silva, D. S., Soares, M. S. P., Teixeira, F. C., de Mello, J. E., de Souza, A. Á., Luduvico, K. P., de Andrade, C. M., Spanevello, R. M., & Cunico, W. J. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03295-0 · Cited by 6
Plant Polyphenols as Dietary Modulators of Brain Functions
Vauzour, D., Kerr, J. S., & Czank, C. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00027-x · Cited by 6
Moadab, A., Khorramdelazad, H., Javar, M. T. A., Rostami‐Nejad, M., Mirzaie, S., Hatami, S., Mahdavi, N., Ghaffari, S., & Yazdian, F. A. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10206-5 · Cited by 8
“Alzheimer’s disease (AD) is a common type of dementia characterized by progressive loss of cognition, chronic neuroinflammation, and impaired elimination of amyloid ‐ β (Aβ) plaques (Vakilian et al. 2019; Thakur et al. 2023; Agostinho et al. 2010).”
Zhou, J., Ran, Y., Qiao, C., Liang, J., Wang, Y., Su, W., Xiao, Y., Ye, L., Xi, J., & Liu, Z. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.164322 · Cited by 6
Exploring the causal relationship between telomere regulation, aging and neurological disorders
Gupta, G., Ali, H., Singh, S. K., Dua, K., & Jha, S. K. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102930 · Cited by 7
Sternberg, Z. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03684-2 · Cited by 6
Exploring the Neuroprotective Effects of Rufinamide in a Streptozotocin-Induced Dementia Model
Kaur, D., Grewal, A. K., Fouad, D., Kumar, A., Singh, V., Alexiou, A. T., Papadakis, M., Batiha, G. E., Welson, N. N., & Singh, T. G. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01521-1 · Cited by 5
“( Agostinho et al. 2010).”
“Methyl jasmonate: bridging plant defense mechanisms and human therapeutics”
Sharma, G., Badruddeen, B., Akhtar, J., Khan, M. I., Ahmad, M. K., & Sharma, P. K. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03752-x · Cited by 5
Sedky, A. A., Raafat, M. H., Hamam, G. G., Sedky, K. A., & Magdy, Y. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00470-0 · Cited by 5
Yang, J., Yin, N., Yang, R., & Faiola, F. (2024) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/s44169-024-00059-z · Cited by 6
“Additionally, an excess of oxidative stress and neuroinflammation plays a pivotal role in AD’s onset and progression, perturbing metabolic processes, immunoregulation, and triggering neuronal death (Agostinho et al. 2010; Song et al. 2021).”
Analyzing Alzheimer’s Disease Research Trends: Insights From Improved Dynamic Topic Modeling
Shen, J., & Mariano, V. Y. (2024) · IEEE Access · doi:10.1109/access.2024.3437656 · Cited by 6
“Factors such as abnormal neuronal metabolism [28], synaptic dysfunction [29], and neuroinflammation [30] have been identified as integral to the disease’s onset, playing a critical role in shaping early diagnosis and therapeutic strategies.”
BackgroundOxidative Stress, Inflammation, and Formation of Beta‐ Amyloid 1‐42 in Brain
Rivas-Arancibia, S., Rodrı́guez-Martı́nez, E., Méndez-García, A., Moctezuma-Salgado, M., Jiménez-Espíndola, P., & López-González, U. (2016) · InTech eBooks · doi:10.5772/64709 · Cited by 5
“The immune defense of the central nervous system (CNS) is composed of a number of small cells known as microglia, astrocytes, and an effective blood‐brain barrier [58].”
Backgroundde la Monte, S. M., & Grammas, P. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch8 · Cited by 7
“Inflammation and oxidative stress are recognized mediators of neurodegeneration in AD (26, 39, 133).”
BackgroundAngarita-Rodríguez, A., Mejía, N. M., González, J., Aristizábal-Pachón, A. F., Hidalgo‐Lanussa, O., Rubio-Mesa, J. J., Barreto, G. E., & Pinzón, A. M. (2022) · Frontiers in Systems Biology · doi:10.3389/fsysb.2022.896265 · Cited by 6
“Moreover, L-carnitine acts on the degradation of fatty acids by β-oxidation, representing a neuroprotective biomarker, leading cells to reduce oxidative stress and improve their energy metabolism (increasing catabolism and the release of lactate and glucose) (Agostinho et al., 2010; Pardo et al., 2013; Schousboe et al…”
BackgroundXu, X.-J., Ding, Y., Zhang, X., Liu, M., Wang, D., Pan, Y., Ren, S., & Liu, X. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105891 · Cited by 5
Oxidative Stress in Neurodegenerative Diseases
Alami, M., Fülöp, T., Boumezough, K., Khalil, A., Zerif, E., & Berrougui, H. (2024) · Springer eBooks · doi:10.1007/978-3-031-69962-7_4 · Cited by 6
Li, J., Kim, K.-W., Oh, H., & Kim, Y. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00871 · Cited by 5
Ali, W., Choe, K., Rehman, I. U., Park, H. Y., Jang, S., Ullah, S., Park, T. J., & Kim, M. O. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10243-0 · Cited by 4
“Microglial cells can either induce or control neuroinflammation (Agostinho et al. 2010).”
Yao, F., Liu, L., Chen, X., Zhang, J., Hao, Z., & He, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02794-1 · Cited by 4
Jung, J., Kim, Y., Cirunduzi, A. C., Yoon, S., Bang, S., & Yang, S. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70919 · Cited by 5
Shen, X., Zheng, C., Lin, R., Wang, J., & Chen, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1795042 · Cited by 5
Stepanichev, M. Y., Markov, D. A., Freiman, S. V., Фролова, О. А., Omelyanchik, S. N., Бородина, Т. А., Novikova, M. R., Канунникова, Н. П., Onufriev, M. V., Мойсеенок, А. Г., et al. (2016) · Neurochemical Journal · doi:10.1134/s1819712416020094 · Cited by 4
Aliaghaei, A., & Meftahi, G. H. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111039 · Cited by 4
“…(NDDs), such as cerebral ischemia (CI), Alzheimer ’ s disease (AD), and Parkinson ’ s disease (PD) has been evaluated (Abushouk et al., 2017; Agostinho et al., 2010; Haddadi et al., 2020; Moghaddam et al., 2021), however; there hasn ’ t been any proven information on how Silymarin affects…”
BackgroundSaadullah, M., Sehar, A., Chauhdary, Z., Siddique, R., Tariq, H., Asif, M., Bukhari, S. A., & Sethi, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311140 · Cited by 6
RetractedProtective Effects of Adaptation to Hypoxia in Experimental Alzheimer’s Disease
Manukhina, E. B., Goryacheva, A. V., Pshennikova, M. G., Malyshev, I. Y., Mallet, R. T., & Downey, H. F. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2906-6_13 · Cited by 5
Vauzour, D., & Minihane, A. M. (2012) · Nutrition and Aging · doi:10.3233/nua-2012-0004 · Cited by 4
Alzheimer’s Disease: An Epidemiologic Disaster From Nutritional Perspective
Péter, S. (2017) · Journal of Nutritional Health & Food Science · doi:10.15226/jnhfs.2017.00184 · Cited by 4
The Neglected Sibling: NLRP2 Inflammasome in the Nervous System
Ducza, L., & Gaál, B. (2023) · Aging and Disease · doi:10.14336/ad.2023.0926-1 · Cited by 3
Curcumin Offers Potential Efficacy for Treating Alzheimer’s Disease
Potter, P. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00010-4 · Cited by 4
Baek, S., Park, S., Shin, J., Lee, J., Kim, H. Y., Han, G., & Kim, Y. S. (2020) · Applied Biological Chemistry · doi:10.1186/s13765-020-00507-z · Cited by 4
Abdel‐Salam, O. M. E., El-Shamarka, M. E.-S., Youness, E. R., et al. (2023) · PubMed · doi:10.22038/ijbms.2022.67871.14845 · Cited by 4
“This results in oxidative stress and neuroinflammation and consequent neuronal cell death (13, 14).”
Duan, Z., Ma, C., Han, Y., et al. (2013) · Neuroreport · doi:10.1097/wnr.0b013e328363fd67 · Cited by 4
Kulak, A. (2012) · Schizophrenia Research · doi:10.1016/s0920-9964(12)70162-7 · Cited by 4
Trivedi, R., Sıngh, S., Singh, V. K., Yadav, S., Singh, A. C., Singh, A., Chaurasia, R. N., Kumar, A., & Kumar, D. (2024) · Brain Organoid and Systems Neuroscience Journal · doi:10.1016/j.bosn.2024.10.001 · Cited by 3
Kushawaha, S. K., Vashisht, K., Kumar, H., Ashawat, M. S., & Baldi, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01981-x · Cited by 3
Flavonoid-Based Derivatives for Modulating Various Targets of Alzheimer’s Disease
Pandey, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_11 · Cited by 3
Lim, J. S., Li, X., Lee, D. Y., Yao, L., Yoo, G., Kim, Y. W., Eum, S. M., Cho, Y.-C., Yoon, S., & Park, S.-J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051932 · Cited by 4
Non-aggregated Aβ25-35 Upregulates Primary Astrocyte Proliferation In Vitro
Ohki, E. C., Langan, T. J., Rodgers, K. R., & Chou, R. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00301 · Cited by 3
“…in the astrocytes of AD brains (Ueberham et al., 2003), in vitro studies demonstrate highly variable and contrasting effects of Aβ on astrocytes (Agostinho et al., 2010), including induction of apoptosis (Brera et al., 2000; Hou et al., 2011; Saha and Biswas, 2015) and oxidative stress (Brera…”
BackgroundNeurochemical Aspects of Alzheimer’s Type of Dementia
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00003-9 · Cited by 4
Стаценко, М. Е., & Туркина, С. В. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112105145 · Cited by 3
Neuropharmacological Properties of Marine Plants
Cho, S., & Kim, S. (2012) · CRC Press eBooks · doi:10.1201/b13868-31 · Cited by 4
Mukherjee, A., Chouhan, G. K., Singh, S., Chatterjee, K., Kumar, A., Gaurav, A. K., Jaiswal, D. K., & Verma, J. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819212-2.00038-4 · Cited by 4
The Overview of Drugs Used in Alzheimer’s Disease and Their Molecular Targets
Vishwas, S., Gulati, M., Babu, M. R., Awasthi, A., Kumar, R., Khursheed, R., Corrie, L., Chaitanya, M., Gupta, G., Devkota, H. P., et al. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_15 · Cited by 4
Pannangrong, W., Nillert, N., Boonyarat, C., Welbat, J. U., Yannasithinon, S., & Choowong-In, P. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04662-4 · Cited by 3
Brain tissue electrical conductivity as a promising biomarker for dementia assessment using MRI
Chu, J., Yao, J., Li, Z., Li, J., Zhang, Y., Liu, C., He, H., Li, B., & Wei, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70270 · Cited by 4
Human induced pluripotent stem cell– based modeling of Alzheimer’s disease, a glial perspective
Chen, X., Yang, Q., Liu, Z., & Shi, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00006-5 · Cited by 4
The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease
Fonseca, A. C. R. G., Resende, R., Cardoso, S. M., & Pereira, C. (2015) · Endoplasmic Reticulum Stress in Diseases · doi:10.1515/ersc-2015-0005 · Cited by 3
“Numerous in vitro studies demonstrate the synaptic and neuronal toxicity induced by Aβ including, but not limited to: evidence of abnormal tau phosphorylation, Ca2+ deregulation, oxidative stress, mitochondrial and endoplasmic reticulum (ER) dysfunction, neuroinflammation, alteration of synaptic transmission, excitoto…”
BackgroundNeuropharmacological Properties of Marine Plants
Kim, S. (2012) · Cited by 4
Ashwlayan, V. D. (2017) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2017.05.00124 · Cited by 3
Magnetic Resonance Spectroscopy (MRS) in Psychiatric Diseases
Lin, A. P., Merugumala, S. K., Liao, H. V., & Sailasuta, N. (2020) · The Wiley Encyclopedia of Health Psychology · doi:10.1002/9781119057840.ch18 · Cited by 3
Guan, T., Li, N., Gao, Y., Gao, M., Hu, Q., Gao, Y., Xiao, L., Yang, Z., & Liu, Q. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143786 · Cited by 4
Lewandowska, M., Różycka, A., Grzelak, T., Kempisty, B., Jagodziński, P. P., Lianeri, M., & Dorszewska, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041634 · Cited by 2
Rajput, M. D., Bawa, P., Kadyan, V., & Sethi, M. (2025) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-025-10427-0 · Cited by 2
Oleanolic Acid and Alzheimer’s Disease: Mechanistic Hypothesis of Therapeutic Potential
Espinosa-Cabello, J. M., Fernández‐Aparicio, Á., González‐Jiménez, E., Perez-Muñoz, G., Castellano, J. M., & Perona, J. S. (2026) · Applied Sciences · doi:10.3390/app16010494 · Cited by 2
Kiani, K., Ramezani, M., Jafari-Gharabaghlou, D., et al. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153496 · Cited by 2
Li, J., Lin, Y., Gao, J., Yang, F., Li, C., Chen, Y., Huang, C., Song, X., Song, Z., Wu, J., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01621-x · Cited by 3
Bhukta, P., Sahu, P. K., & Acharya, B. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100495 · Cited by 2
Deng, J., Liu, P., Lv, B., Guo, J., Liang, F., Tang, J., & Xie, H. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.03.042 · Cited by 2
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 2
Meng, H. W., Lee, A. Y., Kim, H. Y., Cho, E. J., & Kim, J. H. (2022) · Journal of Applied Biological Chemistry · doi:10.3839/jabc.2022.004 · Cited by 2
A review on neurodegenerative diseases associated with oxidative stress and mitochondria
Almalki, W. H., Alshamrani, S. A., Fagieha, R. E., Hallabi, N. H. B., Almatrafi, L. A., & Alahmadi, T. A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.6130 · Cited by 2
Ascorbic acid modulates prefrontal cortex cellular changes in androgen deprived rats
Abayomi, T. A., Tokunbo, O. S., Saka, T. O., Abayomi, O. A., Osuntokun, O. S., & Ajilore, B. S. (2022) · Research Journal of Health Sciences · doi:10.4314/rejhs.v10i2.3 · Cited by 2
Narwanto, M. I., Rahayu, M., Soeharto, S., et al. (2022) · Sains Medika Jurnal Kedokteran dan Kesehatan · doi:10.30659/sainsmed.v13i1.18102 · Cited by 2
“Inflammation and oxidative stress were significant AD pathogenesis pathways (Agostinho et al., 2010).”
BackgroundYaghoubi, A. (2023) · Majallah-i dānishgāh-i ̒ulum-i pizishkī-i Kirmān. · doi:10.34172/jkmu.2023.23 · Cited by 3
“a neuroprotective role by swallowing and clearing Aβ aggregates in the brain (56,57).”
BackgroundImmune Mechanisms in Alzheimer’s Disease: The Role of Toll-Like Receptors Signalling
Sharma, D., Manjunatha, P. M., Babu, T. H., Dhungel, A., Swaraj, S., Janadari, S., Sharma, U., Surendra, V., Taj, N., & Gayathri, S. V. (2024) · Current Pharmacology Reports · doi:10.1007/s40495-024-00376-w · Cited by 3
“…hypothesis” emphasise the vital role of Aβ in AD, with the former proposing that Aβ accumulation (due to reformed processing, overproduction, or absence of the peptide clearance mechanisms) is the primary molecular event triggering neural degeneration in familial and sporadic AD [17, 18].”
Gouri, H., & Bhalla, G. (2025) · Journal of Integrated Science and Technology · doi:10.62110/sciencein.jist.2025.v13.1064 · Cited by 4
Xu, S., Fang, L., Cai, J., Fang, S., Zhu, H., Lin, F., & Cai, X. (2025) · Steroids · doi:10.1016/j.steroids.2025.109588 · Cited by 2
Kwon, Y. R., Kim, J.-H., Lee, S., Kim, H. Y., & Cho, E. J. (2022) · Nutrition Research and Practice · doi:10.4162/nrp.2022.16.2.173 · Cited by 2
“The ROS and free radicals produced through these mechanisms oxidize the cell components, including enzymes and organelles, eventually leading to neuronal damage and cognitive impairment [30].”
BackgroundStudy on Neuroprotective Capacity of Key Flavonoids of Ampelopsis grossedentata
Wang, J.-S., Yu, Z., Yu, Q., Kong, Q., Zhang, N., He, L., & Yi, Y. (2014) · Journal of Food and Nutrition Research · doi:10.12691/jfnr-2-12-4 · Cited by 2
“Recent studies have shown that ROS are involved in Aβ-induced apoptosis [17-21].”
BackgroundThe role of melatonin in preventing ovarian tissue damage in rats exposed to magnetic fields
Küçük, Z., Erkayıran, U., Çaydere, M., et al. (2018) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1707-98 · Cited by 2
Heat Shock Proteins, a Key Modulator of Neuroinflammation in Alzheimer’s Disease
Panchal, K., Bhatt, V., Raval, M., & Tiwari, A. K. (2020) · Heat shock proteins · doi:10.1007/7515_2020_12 · Cited by 2
Guo, P., Cao, C., Ma, Y., & Wang, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02337-9 · Cited by 3
Esawy, A., Eltablawy, N. A., El-Fattah, A. A., & abdalwahab, W. (2021) · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences · doi:10.21608/aijpms.2021.210570 · Cited by 3
Alzheimer’s Disease: An Insightful Review on the Future Trends of the Effective Therapeutics
Hashmi, A., Srivastava, V., Kalam, S. A., & Mishra, D. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102762 · Cited by 2
Górka, M., Białoń, N., Bieczek, D., & Górka, D. (2023) · Postępy Biochemii · doi:10.18388/pb.2021_472 · Cited by 2
Tsvetkova, D. D., Ivanova, S. A., & Obreshkova, D. P. (2023) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/w9frjsnxjp · Cited by 2
Possible involvement of glucocorticoids in mycotoxin-induced neuroinflammation
Chantong, B., & Nusuetrong, P. (2015) · Cited by 2
이혜영, & 이희섭 (2018) · JoLS Journal of Life Sciences · doi:10.5352/jls.2018.28.11.1386 · Cited by 2
Exploring the Therapeutic Power of Flavonoids on Chronic Disease
Ahmad, H. A., Wahab, F., Ullah, M., & Khan, M. I. (2024) · doi:10.1002/9781394238071.ch1 · Cited by 2
Development and in vitro characterization of new carnosine-loaded liposomal formulations
Russo, S., Privitera, A., Greco, G., Pietro, L. D., Cardaci, V., Carota, G., Sarpietro, M. G., & Caruso, G. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2415664 · Cited by 1
“Based on its high therapeutic potential, car-nosine has been proposed for the treatment of different pathological conditions including alzheimer’s [5–7] and Parkinson’s [8,9] diseases. carnosine, due to the presence of serum carnosinases, significantly limiting its bioavailability, and its overall…”
Khatun, M. M., Oni, M., Shadin, M., & Bodiuzzaman, B. S. M. (2025) · Journal of Medicinal Chemistry and Therapeutics · doi:10.71193/jmct.20250001 · Cited by 1
Bhardwaj, S., Jindal, A., Singh, S., Kaur, R., & Grewal, A. K. (2025) · Assay and Drug Development Technologies · doi:10.1089/adt.2024.130 · Cited by 1
Nabizadeh, A., Rafati, A., Karbalaei, N., Namavar, M. R., Hosseinzadeh, S., Jahromi, H. M., Rahimi, A., & Naseh, M. (2025) · Brain Structure and Function · doi:10.1007/s00429-025-03003-6 · Cited by 3
“Among these, oxidative stress and neuroinflammation are considered early and central events in AD develop - ment (Uddin et al. 2022; Agostinho et al. 2010).”
He, F., Hofmann, J., Poeta, E., Monti, B., Crouzier, L., Maurice, T., & Decker, M. W. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118068 · Cited by 1
Chronobiology and Neurodegeneration: The Role of Melatonin in Alzheimer's Disease
Vaja, R., Vohra, M., Ramachandran, A. V., & Baxi, D. B. (2025) · Nutritional Psychiatry · doi:10.1016/j.nupsyc.2025.100001 · Cited by 1
Khan, M. S., Ahmad, A., Nasiripour, S., & Bopassa, J. C. (2026) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad3010005 · Cited by 1
“Additionally, anthocyanins enhance insulin sensitivity, improve pancreatic β -cell function, and inhibit insulin resistance-driven dysregulation of insulin-degrading enzyme (IDE), which impairs A β clearance and exacerbates AD-related neurodegeneration [99–115].”
Said, M. F., El‐Shiekh, R. A., Wadie, W., El-Haleim, E. A. A., Hamouda, H. A., & El-Zoheiry, H. H. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109774 · Cited by 3
Unhealthy dietary patterns and Alzheimer’s disease: associations and underlying mechanistic pathways
Ramasinghe, C., & Xu, B. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2691237 · Cited by 1
“This is associated with increased oxidative damage and has been linked to enhanced aggregation of Aβ and tau proteins (Agostinho et al. 2010; Chun et al. 2020).”
HMGB1 signalling in Alzheimer’s disease: pathogenic roles and therapeutic prospects
Tyagi, P., Kumari, S., Sharma, P., Dhapola, R., Paidlewar, M., Medhi, B., & HariKrishnaReddy, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117204 · Cited by 2
Effects of 3-n-Butylphthalide from Celery on Vascular Dementia
Liang, W., Cheung, D. W.-S., Tang, H. C., Lam, W. P., Zhang, L., Leung, P., & Yew, D. T.-W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00089-6 · Cited by 1
Microglia, Calcification and Neurodegenerative Diseases
Jose, M., Mahy, N., & Manuel, J. (2011) · InTech eBooks · doi:10.5772/28464 · Cited by 1
“For example, PD and AD are both regarded as diseases that are initiated by neuronal death to which the immune system responds, as evidenced by astroglial and microglial activation with pathogenic consequences (Agostinho et al., 2010, Halliday & Stevens, 2011).”
BackgroundBalin, B. J., Hammond, C. J., Zoga, J. D., Cader, A., Slutter, A., Anzman, J. M., Kohler, I., Hingley, S. T., & Appelt, D. M. (2013) · Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine) · Cited by 1
Isolation and Culture of Human Neurons, Microglia, and Astrocytes
Wu, L., & Gorantla, S. (2013) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4614-8794-4_7 · Cited by 1
Effect of Mediterranean Diet on Healthy Brain Aging
Boccardi, V., Tinarelli, C., & Mecocci, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00006-7 · Cited by 1
Pokkunuri, S., & Kimberly, P. (2022) · Journal of Emerging Investigators · doi:10.59720/21-257 · Cited by 1
“Feeding and lifespan assay Flies were fed fresh individual and mixed plant extract (20-21) corn meal medium (1 mg/mL, 2 mg/mL, 3 mg/mL) or regular corn meal post-eclosion.”
BackgroundMethodUncovering the Biological Applications of Cinnamic Acid Derivatives: A Patent Review
Porto, R., & Porto, V. A. (2023) · Letters in Drug Design & Discovery · doi:10.2174/0115701808273623231009074241 · Cited by 1
Cellular and molecular mechanisms of ammonia-induced neurotoxicity: a neurotherapeutic prospect
Heidari, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00075-0 · Cited by 1
Muñoz-Acevedo, A., Guzmán, C. P., Contreras, O. J. C., Gutiérrez, R. G., & Díaz, M. C. (2023) · Springer eBooks · doi:10.1007/978-981-99-7731-4_7 · Cited by 1
Pathophysiology and Management Approaches in Alzheimer’s Disease
Jain, S., Goel, D., Nazir, S. S., Yadav, V., & Vohora, D. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_4 · Cited by 2
Metadata
- Authors
- Agostinho, P., A. Cunha, R., & Oliveira, C.
- Affiliations
- University of Coimbra (PT)
- Corresponding author
- Oliveira, Catarina
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-08-01
- Volume
- 16
- Issue
- 25
- Pages
- 2766-2778
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2114324710
- Cited by
- 685
- References
- 0
- Citations by year
- 2026: 35 · 2025: 44 · 2024: 46 · 2023: 43 · 2022: 52 · 2021: 61 · 2020: 58 · 2019: 42 · 2018: 44 · 2017: 51 · 2016: 32 · 2015: 36 · 2014: 34 · 2013: 37 · 2012: 41
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, oxidative stress, amyloid-beta oligomers, amyloid plaques, microglia, astrocytes, neurodegeneration, inflammatory cytokines, chemokines, complement system, reactive oxygen species, reactive nitrogen species, synaptic loss, memory impairment, mild cognitive impairment, glial activation, antioxidants, curcumin, quercetin, glial scar, calcium overload, PPARγ
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Brain, Humans, Models, Neurological, Nerve Degeneration, Neuroglia, Drug Delivery Systems, Oxidative Stress, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review